← All stocks

Incyte

INCY Net buying
CIK 0000879169 #251 in the set updated 17 Sep 2026
Bought (120 mo)
$302.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$244.18M
$53.43M on a plan · $162.91M straight out of an exercise
Sold at will
$27.84M
48 of 301 sales
Net
+$57.82M
+$274.16M against sales at will

By person

39 insiders · 401 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAKER BROS. ADVISORS LP entity
Director
$299.55M (40)
+$299.55M
28,486,950
14.05%
$3.58B
−8.5%
Hoppenot Herve
Director
$1.91M (2)
$50.85M (6) scheduled
−$48.93M
326,803
0.1612%
$41.03M
−14.4%
Stein Steven H
CMO & Head of Late-Stage Dev.
$28.29M (35) scheduled
−$28.29M
30,916
0.0153%
$3.88M
+56.8%
FRIEDMAN PAUL A
Director
$24.72M (6) scheduled
−$24.72M
256,813
0.1267%
$32.25M
−9.1%
SWAIN PAULA J
EVP, Human Resources
$23.07M (29) scheduled
−$23.07M
106,482
0.0525%
$13.37M
+264.1%
Flannelly Barry P
EVP & General Manager US
$16.16M (34) scheduled
−$16.16M
35,149
0.0173%
$4.41M
+143.6%
Wenqing Yao
EVP, Head of Discovery Chem
$13.63M (13) scheduled
−$13.63M
98,575
0.0486%
$12.38M
−28.6%
CAGNONI PABLO J
President, Global Head of R&D
$11.30M (7) scheduled
−$11.30M
183,200
0.0904%
$23.00M
+1,016%
Pasquale Maria E
EVP & General Counsel
$9.67M (17) scheduled
−$9.67M
69,724
0.0344%
$8.75M
+7,554%
GRYSKA DAVID W
Executive Vice President, CFO
$9.18M (8) scheduled
−$9.18M
10,235
0.0050%
$1.29M
−46.2%
Trower Paul
Principal Accounting Officer
$8.64M (17) scheduled
−$8.64M
32,268
0.0159%
$4.05M
+151.7%
Iyengar Vijay K
EVP, GMAPPS
$8.24M (25) scheduled
−$8.24M
40,540
0.0200%
$5.09M
+401.1%
Morrissey Michael James
EVP, Head of Tech. Operations
$7.30M (4) scheduled
−$7.30M
34,065
0.0168%
$4.28M
−20.9%
DIXON WENDY L
Director
$6.81M (6) scheduled
−$6.81M
17,768
0.0088%
$2.23M
+112.1%
Mayes Patrick A
EVP & Chief Scientific Officer
$6.56M (15) scheduled
−$6.56M
61,441
0.0303%
$7.71M
−8.8%
Huber Reid M
EVP, Chief Scientific Officer
$4.28M (7)
−$4.28M
34,571
0.0171%
$4.34M
−49.9%
BROOKE PAUL A
Director
$2.96M (1) scheduled
−$2.96M
261,911
0.1292%
$32.89M
+33.4%
Denton Sheila A.
EVP & General Counsel
$2.14M (16) scheduled
−$2.14M
26,569
0.0131%
$3.34M
+3,950%
Dickinson Jonathan Elliott
EVP, General Manager, Europe
$2.02M (4)
−$2.02M
36,390
0.0180%
$4.57M
+36.1%
Dhanak Dashyant
EVP & Chief Scientific Officer
$1.87M (20) scheduled
−$1.87M
58,968
0.0291%
$7.40M
Siegel Eric H.
EVP, General Counsel
$1.75M (7) scheduled
−$1.75M
21,053
0.0104%
$2.64M
+43.0%
Tray Thomas
Principal Accounting Officer
$1.51M (17) scheduled
−$1.51M
21,699
0.0107%
$2.72M
+22.9%
Clancy Paul J
Director
$1.42M (1) scheduled
−$1.42M
25,635
0.0126%
$3.22M
Issa Mohamed Khairie
EVP, Head of U.S. Commercial
$1.31M (2) scheduled
−$1.31M
71,797
0.0354%
$9.01M
BIENAIME JEAN JACQUES
Director
$533.44K (7)
$212.89K (3)
+$320.55K
24,424
0.0120%
$3.07M
+3,064%
Heeson Lee
EVP, Head of Incyte Intl
$289.02K (1) scheduled
−$289.02K
38,041
0.0188%
$4.78M
BAKER JULIAN
Director
767,095
0.3784%
$96.32M
Meury William
Chief Executive Officer
183,129
0.0903%
$22.99M
Stamoulis Christiana
EVP & Chief Financial Officer
125,759
0.0620%
$15.79M
+6,346%
Upadhyay Suketu
EVP & Chief Financial Officer
26,343
0.0130%
$3.31M
HARRIGAN EDMUND
Director
23,019
0.0114%
$2.89M
FOUSE JACQUALYN A
Director
20,968
0.0103%
$2.63M
Hoffman Richard A.
EVP & General Counsel
16,861
0.0083%
$2.12M
Gardner David H
EVP, Chief Strategy Officer
16,824
0.0083%
$2.11M
High Katherine A
Director
14,983
0.0074%
$1.88M
Trotta Matteo
EVP, GM, Dermatology US
14,882
0.0073%
$1.87M
+3,593%
BRAWLEY OTIS W
Director
12,894
0.0064%
$1.62M
Basi Ramitpal K
EVP, Human Resources
10,993
0.0054%
$1.38M
Schaffert Susanne
Director
7,389
0.0036%
$927.76K
Insider
Date
Role
Action
Shares
Price
Amount
Mayes Patrick A
5 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
2,207
$123.99
$273.65K
Mayes Patrick A
3 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
6,055
$120.43
$729.20K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,293
$119.41
$273.81K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
326
$121.69
$39.67K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
85
$122.19
$10.39K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,642
$119.38
$196.02K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,643
$119.51
$196.35K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,864
$119.40
$341.96K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
4,695
$119.39
$560.54K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
6,171
$119.43
$737.00K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,187
$119.47
$261.28K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
5,332
$119.42
$636.75K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
14,661
$119.46
$1.75M
Tray Thomas
4 Jun 2026
Principal Accounting Officer
Sold after exercise
2,639
$100.00
$263.90K
Clancy Paul J
19 May 2026
Director
Sold after exercise
15,000
$94.93
$1.42M
CAGNONI PABLO J
17 Apr 2026
President, Global Head of R&D
Sold after exercise
18,667
$96.50
$1.80M
CAGNONI PABLO J
17 Mar 2026
President, R&D
Sold after exercise
18,667
$94.24
$1.76M
CAGNONI PABLO J
19 Feb 2026
President, R&D
Sold after exercise
18,668
$100.91
$1.88M
Tray Thomas
19 Dec 2025
Principal Accounting Officer
Sold after exercise
2,774
$100.00
$277.40K
Denton Sheila A.
17 Nov 2025
EVP & General Counsel
Sold after exercise
278
$104.36
$29.01K
Stein Steven H
5 Nov 2025
EVP & Chief Medical Officer
Sold after exercise
5,233
$102.20
$534.81K
Denton Sheila A.
4 Nov 2025
EVP & General Counsel
Sold after exercise
598
$101.36
$60.61K
Denton Sheila A.
15 Oct 2025
EVP & General Counsel
Sold after exercise
277
$85.13
$23.58K
Denton Sheila A.
2 Oct 2025
EVP & General Counsel
Sold after exercise
599
$87.65
$52.50K
Denton Sheila A.
16 Sep 2025
EVP & General Counsel
Sold after exercise
278
$83.15
$23.12K
Denton Sheila A.
2 Sep 2025
EVP & General Counsel
Sold after exercise
598
$84.97
$50.81K
Denton Sheila A.
15 Aug 2025
EVP & General Counsel
Sold after exercise
277
$86.81
$24.05K
Denton Sheila A.
4 Aug 2025
EVP & General Counsel
Sold after exercise
598
$75.77
$45.31K
Denton Sheila A.
15 Jul 2025
EVP & General Counsel
Sold after exercise
3,330
$69.86
$232.63K
Denton Sheila A.
2 Jul 2025
EVP & General Counsel
Sold after exercise
599
$68.61
$41.10K
Denton Sheila A.
3 Jun 2025
EVP & General Counsel
Sold after exercise
1,795
$68.00
$122.06K
Denton Sheila A.
4 Mar 2025
EVP & General Counsel
Sold after exercise
599
$69.99
$41.92K
Denton Sheila A.
26 Feb 2025
EVP & General Counsel
Sold after exercise
4,495
$74.08
$332.99K
Denton Sheila A.
26 Feb 2025
EVP & General Counsel
Sold after exercise
9,574
$74.07
$709.15K
Flannelly Barry P
6 Nov 2024
EVP & General Manager US
Sold after exercise
2,256
$78.21
$176.44K
Flannelly Barry P
6 Nov 2024
EVP & General Manager US
Sold after exercise
1,424
$82.00
$116.77K
Pasquale Maria E
31 Jan 2023
EVP & General Counsel
Sold after exercise
802
$84.06
$67.42K
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
4,842
$84.73
$410.26K
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
5,644
$85.07
$480.14K
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
14,374
$84.73
$1.22M
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
11,861
$84.70
$1.00M
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
10,438
$84.70
$884.10K
Pasquale Maria E
30 Jan 2023
EVP & General Counsel
Sold after exercise
12,865
$84.69
$1.09M
Iyengar Vijay K
26 Jan 2023
EVP, GMAPPS
Sold after exercise
7,000
$85.00
$595.00K
Iyengar Vijay K
23 Dec 2022
EVP, GMAPPS
Sold after exercise
1,654
$80.79
$133.63K
Iyengar Vijay K
23 Dec 2022
EVP, GMAPPS
Sold after exercise
804
$80.77
$64.94K
Iyengar Vijay K
23 Dec 2022
EVP, GMAPPS
Sold after exercise
7,000
$80.80
$565.60K
Iyengar Vijay K
23 Dec 2022
EVP, GMAPPS
Sold after exercise
7,866
$80.80
$635.57K
Flannelly Barry P
8 Apr 2022
EVP & General Manager US
Sold after exercise
1,248
$82.96
$103.53K
Flannelly Barry P
8 Apr 2022
EVP & General Manager US
Sold after exercise
881
$82.96
$73.09K
Flannelly Barry P
8 Apr 2022
EVP & General Manager US
Sold after exercise
21,348
$84.00
$1.79M
Flannelly Barry P
8 Apr 2022
EVP & General Manager US
Sold after exercise
20,516
$83.01
$1.70M
SWAIN PAULA J
7 Jan 2022
EVP, Human Resources
Sold after exercise
10,870
$73.31
$796.88K
SWAIN PAULA J
4 Jan 2022
EVP, Human Resources
Sold after exercise
9,319
$73.46
$684.57K
Trower Paul
3 Jan 2022
Principal Accounting Officer
Sold after exercise
1,396
$73.31
$102.34K
Trower Paul
3 Jan 2022
Principal Accounting Officer
Sold after exercise
6,818
$73.31
$499.83K
DIXON WENDY L
23 Dec 2021
Director
Sold after exercise
20,000
$22.05
$441.00K
Dhanak Dashyant
10 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
3,845
$87.00
$334.52K
Dhanak Dashyant
1 Feb 2021
EVP & Chief Scientific Officer
Sold after exercise
395
$90.00
$35.55K
Dhanak Dashyant
1 Feb 2021
EVP & Chief Scientific Officer
Sold after exercise
961
$90.00
$86.49K
Iyengar Vijay K
25 Jan 2021
EVP GPS, BD, & Licensing
Sold after exercise
1,000
$99.00
$99.00K
Iyengar Vijay K
25 Jan 2021
EVP GPS, BD, & Licensing
Sold after exercise
4,116
$99.00
$407.48K
Stein Steven H
25 Jan 2021
EVP & Chief Medical Officer
Sold after exercise
3,795
$100.00
$379.50K
Wenqing Yao
25 Jan 2021
EVP, Head of Discovery Chem
Sold after exercise
19,986
$100.00
$2.00M
Wenqing Yao
25 Jan 2021
EVP, Head of Discovery Chem
Sold after exercise
1,559
$100.00
$155.90K
Dhanak Dashyant
6 Nov 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$85.17
$81.85K
Flannelly Barry P
2 Nov 2020
EVP & General Manager US
Sold after exercise
20,000
$86.60
$1.73M
Pasquale Maria E
9 Oct 2020
EVP & General Counsel
Sold after exercise
1,423
$95.00
$135.19K
Dhanak Dashyant
6 Oct 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$91.97
$88.38K
Pasquale Maria E
10 Sep 2020
EVP & General Counsel
Sold after exercise
2,193
$90.83
$199.19K
Dhanak Dashyant
8 Sep 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$88.94
$85.47K
DIXON WENDY L
27 Aug 2020
Director
Sold after exercise
20,000
$94.51
$1.89M
Dhanak Dashyant
6 Aug 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$97.80
$93.99K
Hoppenot Herve
7 Jul 2020
Chairman / CEO
Sold after exercise
88,406
$110.00
$9.72M
Hoppenot Herve
7 Jul 2020
Chairman / CEO
Sold after exercise
1,365
$110.00
$150.15K
Stein Steven H
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
3,283
$107.99
$354.53K
Stein Steven H
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
7,495
$110.04
$824.75K
Stein Steven H
7 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
3,381
$110.04
$372.05K
Dhanak Dashyant
6 Jul 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$106.58
$102.42K
Stein Steven H
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
10,437
$107.31
$1.12M
Stein Steven H
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
10,437
$107.31
$1.12M
Stein Steven H
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
12,132
$107.31
$1.30M
Stein Steven H
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
596
$107.31
$63.96K
Stein Steven H
6 Jul 2020
EVP & Chief Medical Officer
Sold after exercise
2,522
$106.40
$268.34K
Wenqing Yao
6 Jul 2020
EVP, Head of Discovery Chem
Sold after exercise
15,648
$107.32
$1.68M
Wenqing Yao
6 Jul 2020
EVP, Head of Discovery Chem
Sold after exercise
905
$107.32
$97.12K
Hoppenot Herve
26 Jun 2020
Chairman / CEO
Sold after exercise
119,501
$102.91
$12.30M
Hoppenot Herve
26 Jun 2020
Chairman / CEO
Sold after exercise
4,647
$102.91
$478.22K
Flannelly Barry P
23 Jun 2020
EVP & General Manager US
Sold after exercise
400
$110.00
$44.00K
Trower Paul
23 Jun 2020
Principal Accounting Officer
Sold after exercise
6,943
$110.00
$763.73K
Flannelly Barry P
19 Jun 2020
EVP & General Manager US
Sold after exercise
7,181
$105.00
$754.01K
Iyengar Vijay K
19 Jun 2020
EVP GPS, BD, & Licensing
Sold after exercise
7,866
$105.00
$825.93K
Pasquale Maria E
19 Jun 2020
EVP & General Counsel
Sold after exercise
1,423
$100.00
$142.30K
Pasquale Maria E
10 Jun 2020
EVP & General Counsel
Sold after exercise
2,192
$94.19
$206.46K
Pasquale Maria E
10 Jun 2020
EVP & General Counsel
Sold after exercise
1,423
$95.00
$135.19K
Dhanak Dashyant
8 Jun 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$91.87
$88.29K
Dhanak Dashyant
6 May 2020
EVP & Chief Scientific Officer
Sold after exercise
961
$96.84
$93.06K
Pasquale Maria E
17 Apr 2020
EVP & General Counsel
Sold after exercise
9,488
$100.00
$948.80K
Showing 250 of 401 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 919
Amendments (4/A) skipped 3
Filings about a different issuer 4
Unreadable filings 0
Joint filings 64
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 195
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 24,683,547
Sales filed before the plan box existed 47
History held since 26 Sep 2016